Tom Russo's JNJ Position Overview
Tom Russo (via Gardner Russo & Quinn LLC) currently holds 1,112 shares of Johnson & Johnson (JNJ) worth $282,415, representing 0.00% of the portfolio. First purchased in 2016-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Tom Russo has maintained a strategic position in JNJ, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2017, adding 1,315 shares. Largest reduction occurred in Q3 2016, reducing 2,050 shares.
Analysis based on 13F filings available since 2013 Q2
Tom Russo's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Tom Russo
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -192 | Reduce 14.72% | 1,112 | $253.97 |
| Q1 2026 | +328 | Add 33.61% | 1,304 | $244.44 |
| Q4 2025 | +976 | New Buy | 976 | $206.95 |
| Q3 2018 | -1,715 | Sold Out | 0 | $0.00 |
| Q1 2018 | +400 | Add 30.42% | 1,715 | $128.28 |
| Q4 2017 | +1,315 | New Buy | 1,315 | $139.92 |
| Q3 2016 | -2,050 | Sold Out | 0 | $0.00 |
| Q2 2016 | +2,050 | New Buy | 2,050 | $121.46 |
Tom Russo's Johnson & Johnson Investment FAQs
Tom Russo first purchased Johnson & Johnson (JNJ) in Q2 2016, acquiring 2,050 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tom Russo has held Johnson & Johnson (JNJ) for 9 quarters since Q2 2016.
Tom Russo's largest addition to Johnson & Johnson (JNJ) was in Q2 2016, adding 2,050 shares worth $249,000.
According to the latest 13F filing for Q2 2026, Tom Russo's firm, Gardner Russo & Quinn LLC, owns 1,112 shares of Johnson & Johnson (JNJ), valued at approximately $282,415.
As of the Q2 2026 filing, Johnson & Johnson (JNJ) represents approximately 0.00% of Tom Russo's publicly disclosed stock portfolio, making it one of their key holdings.
Tom Russo's peak holding in Johnson & Johnson (JNJ) was 2,050 shares, as reported at the end of Q2 2016.